Table 1.
Summary of the adverse, neutral, and beneficial effects of melatonin in rheumatoid arthritis.
Adverse/Neutral/Beneficial | Sample/Animal Model/Cell Line | Melatonin Level | Effects | References | |
---|---|---|---|---|---|
Adverse | CIA mice |
![]() |
RA |
![]() |
[40] |
Adverse | CIA mice (pinealectomy) |
![]() |
Serum anti-CII RA |
![]() |
[41] |
Adverse | RA synovial macrophages/myeloid monocytic cells (THP-1) |
![]() |
IL-12 NO |
![]() |
[33] |
Adverse | CIA rats |
![]() |
Anti-collagen antibodies IL-1β and IL-6 |
![]() |
[32] |
Neutral | Treatment with melatonin | Erythrocyte sedimentation rate (ESR) and neopterin |
![]() |
[35] | |
Neutral | RA patients’ plasma levels |
![]() |
[36] | ||
Beneficial | Treatment with melatonin | MMP-9 |
![]() |
[46] | |
Beneficial | Fibroblast-like synoviocytes (FLS) | Treatment with melatonin | P21/P27 FLS proliferation |
![]() ![]() |
[48] |
Beneficial | Synovial fibroblasts | Treatment with melatonin | miR-3150a-3p IL-1β and TNF-α |
![]() ![]() |
[20] |
Beneficial | Treatment with melatonin | TLR/MAPK Nrf2 |
![]() ![]() |
[15] | |
Beneficial | Treatment with melatonin | ROS and RNS glutathione and antioxidant enzymes |
![]() ![]() |
[28] | |
Beneficial | Osteoblast cells | Treatment with melatonin | miR-590-3p Apoptosis |
![]() ![]() |
[55] |